| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |